The international HIV dementia scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé - Cameroon

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 4, 2008, Pages 393-397

  Njamnshi, Alfred K ^a,b   Djientcheu, Vincent De Paul ^c   Fonsah, Julius Y ^a,b   Yepnjio, Faustin N ^b   Njamnshi, Dora M ^b   Muna, Walinjom F ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^c NONE

Author keywords

Cameroon; Cognitive impairment; Dementia; HIV AIDS; IHDS; Sub Saharan Africa

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CAMEROON; CASE CONTROL STUDY; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RATING SCALE; SCREENING;

ADOLESCENT; ADULT; AIDS DEMENTIA COMPLEX; CAMEROON; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 57649134464     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318183a9df     Document Type: Article

References (16)

1. Brion JP, Leclerc P, Bosseraya A. Les atteintes neurologiques du SIDA. Ann psychiatrie. 1992;7:37-46.
2. Wong M, Robertson R, Nakasujja N, et al. HIV-associated neurological complications among HIV-seropositive individuals in Uganda. Neurology. 2004;62:444.
3. McArthur JC, Sacktor N, Riedel D, et al. Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C-infected population in India. J Neurovirol. 2006;12:34-38.
4. Dongmo L, Njamnshi AK, Kaptue LN, et al. Aspects cliniques et étiologiques des encéphalopathies chez le sujet VIH positif à Yaoundé. Journal Camerounais de Médecine. 2003;12(1):11-12.
5. Ongolo-Zogo P, Amana JP, Njamnshi AK, et al. Aspects cliniques et scanographiques des lésions cérébrales chez l'adulte camerounais VIH positif: à propos de 94 cas. Health Sci Dis. 2000;2:17-22.
6. Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology. 2001;56(2):257-260 [Medline].
7. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol. 2002;8(Suppl):115-121.
8. Tozzi V, Balestra P, Murri R, et al. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS. 2004;15:254-259.
9. McArthur JC, Cohen BA, Selnes OA, et al. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-infected individuals: results from the Multicenter AIDS Cohort Study. Ann Neurol. 1989;26:601-611.
10. Sacktor NC, Bacellar H, Hoover DR, et al. Psychomotor slowing in HIV infection. A predictor of dementia, AIDS and death. J Neurovirol. 1996;2:404-410.
11. Hinkin CH, Hardy DJ, Mason KL, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl 1):S19-S25.
12. Sacktor N, Lyles RH, Skolasky RL, et al. Combination antiretroviral therapy improves psychomotor speed performance in HIV+ homosexual men. Neurology. 1999;52:1640-1647.
13. Sacktor N, Skolasky RL, Lyles RH, et al. Improvement in HIV-associated motor slowing after ARV therapy including protease inhibitors. J Neurovirol. 2000;6:84-88 [Medline].
14. McArthur J, Brew B, Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005;4:543-555.
15. Bryden MP. Measuring handedness with questionnaires. Neuropsychologia. 1977;15:617-624.
16. Sacktor NC, Wong M, Nakasujja N, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS. 2005;19:1367-1374.